Bill could end holdup for California research on psychedelics and addiction treatment

California lawmakers are working to address a bureaucratic logjam that has hindered numerous studies on addiction treatment and psychedelics due to the Research Advisory Panel of California, established to approve studies involving controlled substances like cannabis and hallucinogens.

The panel's ceasing of meetings since August, due to concerns around the legality of holding closed-door sessions under the Bagley-Keene Act, has created a backlog of 42 new studies and 28 amendments awaiting approval, affecting crucial research efforts, including those exploring the health risks of cannabis use for specific age groups.

Read at Los Angeles Times